GSK teams up with Strathclyde and University of Nottingham

pharmafile | July 16, 2019 | News story | Manufacturing and Production GSK, GlaxoSmithKline, UK, britain, pharma, universities 

GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at promoting new medical research.

The £12.9 million project has received £5.5 million in funding from the Engineering and Physical Sciences Research Council (ESPRC).

The partnership will see the three organisations team up to use machine learning and AI to identify new medicines and make the production of medicines more environmentally friendly.  

The project is also intended to train a new cohort of postgraduate students and postdoctoral researchers.

Tony Wood, Senior Vice President, Medicinal Science & Technology at GSK said: “We are delighted with the EPSRC award which recognises the important work being done in collaboration with Nottingham and Strathclyde Universities. 

“Together we are focused on the application of Artificial Intelligence/Machine Learning in synthetic chemistry, a discipline that is central to drug design and development of new medicines. The additional support will enable continued research hopefully delivering efficiency gains that bring meaningful benefit to the discovery of new medicines.” 

Louis Goss

Related Content

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

UK-based pharmaceutical company AstraZeneca has announced that the National Institute for Health and Care Excellence …


GSK’s RSV vaccine approved in EU for older adults

GSK has announced that the European Commission (EC) has authorised Arexvy, the company’s respiratory syncytial …

GSK receives FDA file acceptance for Jemperli plus chemotherapy for treating endometrial cancer

GSK has announced that the US Food and Drug Administration (FDA) has accepted the supplemental …

Latest content